EICHORPublic-registry site landscape for NCT07749716, “Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata”, a Alopecia Areata study sponsored by Jiangsu vcare pharmaceutical technology co., LTD. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07749716 (registry record) |
| Study title | Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Subjects With Severe Alopecia Areata |
| Sponsor | Jiangsu vcare pharmaceutical technology co., LTD |
| Condition(s) | Alopecia Areata |
| Phase | PHASE2 |
| Listed sites | 1 |
| Intervention(s) | Drug: VC005 tablets, VC005 tablets, VC005 placebo tablets |
| Site countries | China |
Patient-friendly overview of this study: eichor.com/study/NCT07749716.
Eichor generates a preliminary site-risk snapshot for NCT07749716 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
